Dynamic Technology Lab’s SpringWorks Therapeutics SWTX Stock Holding History

Dynamic Technology Lab’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,717	Closed	-$439K	–	1339
2024 Q3	$439K	Buy	+13,717	New	+$512K	0.05%	611
2024 Q2	–	Sell	-8,260	Closed	-$407K	–	1373
2024 Q1	$407K	Buy	+8,260	New	+$382K	0.04%	674
2023 Q2	–	Sell	-21,650	Closed	-$557K	–	1406
2023 Q1	$557K	Buy	+21,650	New	+$633K	0.05%	583
2022 Q2	–	Sell	-5,080	Closed	-$287K	–	1521
2022 Q1	$287K	Sell	5,080 -5,810	-53%	-$332K	0.03%	805
2021 Q4	$675K	Buy	10,890 +3,260	+43%	+$216K	0.07%	456
2021 Q3	$484K	Buy	7,630 +3,130	+70%	+$241K	0.06%	542
2021 Q2	$371K	Buy	+4,500	New	+$342K	0.04%	697

Other funds holding SWTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dynamic Technology Lab's SWTX Position: Q4 2024 in Review

Dynamic Technology Lab sold out of SpringWorks Therapeutics (SWTX) in Q4 2024, closing a stake of 13,717 shares — an estimated $439K sold.

Dynamic Technology Lab first reported a position in SWTX in Q2 2021 and held it in 7 quarters. The position peaked at $675K in Q4 2021. 216 funds tracked by Wall St. Rank hold SWTX as of Q4 2024.

Dynamic Technology Lab reported no remaining SpringWorks Therapeutics position as of Q4 2024 after selling out during the quarter.
Dynamic Technology Lab sold 13,717 SpringWorks Therapeutics shares in Q4 2024, an estimated $439K.
Dynamic Technology Lab first reported a position in SpringWorks Therapeutics in Q2 2021 and held it in 7 quarters.
Dynamic Technology Lab's SpringWorks Therapeutics position peaked at $675K in Q4 2021.
216 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.